In a study of predominantly low-income and Black Americans ages 65 and older, the researchers found that those with the longest “sitting time” — more than 10 hours a day — had the highest mortality risk.

A kidney protein that responds to low levels of blood potassium — which can cause high blood pressure and cardiovascular problems — may be a target for new therapeutics.

The research could lead to treatments that restore nerve activity through the targeted delivery of electromagnetic stimuli or drugs.

A target of their investigations is serotonin, a signaling molecule that is well known for its critical roles in regulating mood and which also plays an important role in the development of the brain and nervous system.

With a $3 million research grant, Henrique Serezani will investigate how altered metabolism in diabetes affects inflammation and sepsis.

The research shows that by getting enough sleep and reducing variability around sleep onset and wake times, patients can reduce the incidence of chronic disease.

Sweeping data integration and clinical trial simulations are needed to help decide which targets to prioritize in researching new tuberculosis treatment regimens.